Journal: Blood Advances
Article Title: Loss of p 53 enhances the tumor-initiating potential and drug resistance of clonogenic multiple myeloma cells
doi: 10.1182/bloodadvances.2022009387
Figure Lengend Snippet: Loss of p 53 enhances the tumor-initiating potential of MM cells. (A) Growth curves of p 53-wt (Scr) and p 53-KO MM.1S, MM.1R, MOLP8, NCI-H929, and KMS11 cells (n = 3). (B) Primary (1°) and secondary (2°) colony formation of p 53-wt (Scr) and p 53-KO MM.1S, MOLP8, and NCI-H929 cells (n = 5). (C) Colony formation of p 53-wt (Scr) and p 53-KO MM.1R cells (n = 3). (D) Colony formation of p 53-null KMS11 (Ctrl) and KMS11 p 53-overexpression cells (n = 3). (E) Frequency of CD138 neg and ALDH + cells within Scr and p 53-KO MM.1S, MM.1R, and MOLP8 cell lines by flow cytometry (n = 6).
Article Snippet: For Notch intracellular domain (NICD) overexpression, the NICD fragment (from TetO-FUW-NICD; Addgene) was cloned into the pINDUCER21 (Addgene) lentiviral vector, then transfected into MM.1S p 53-KO cells.
Techniques: Over Expression, Flow Cytometry